Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Swiss Exchange  >  SGS    SGSN   CH0002497458

SGS (SGSN)
Mes dernières consult.
Most popular
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

SGS : Expands and Increases Capacity by 50% at its Lincolnshire, IL Facility

share with twitter share with LinkedIn share with facebook
share via e-mail
0
08/08/2017 | 03:45pm CEST

SGS, a leading bio/pharmaceutical analytical and bioanalytical contract solutions provider, is expanding its facility in Lincolnshire, in the northern suburbs of Chicago, Illinois.

The expansion will increase the site's current footprint from 38,500 sq. ft. to nearly 58,000 sq. ft. and is due to be completed by September 2017.

The expansion will allow the facility to increase capacity for the wide range of services that it offers, including analytical method development and testing, microbiological evaluation, drug stability studies, testing of containers and medical devices, and utilities qualification and monitoring. Additional staff will be employed to meet the demands on the laboratory.

'This investment allows us to be flexible in our approach to meeting both existing and future customer demands,' commented James Nokes, Vice President, U.S. Agriculture, Food and Life. 'Analysis and bioanalysis techniques continue to evolve rapidly, and are driven by technological advances and regulatory needs. At SGS, it is our aim to ensure we can offer our clients integrated solutions to support their needs, so we continue to invest in capabilities, capacity and our staff to maintain our professionalism and efficiency.'

The expansion at SGS's Lincolnshire site follows a series of recent investments at the company's global laboratory network. Increases in extractables and leachables capabilities have taken place at Fairfield, NJ and Shanghai, China; while French facilities at Poitiers and Villeneuve-la-Garenne have seen investment in bioanalytical capabilities and elemental analysis respectively.

With 20 laboratories offering contract analytical and bioanalytical services, SGS leverages its wholly-owned global network, present in North America, Europe, and Asia, to deliver harmonized solutions to large pharmaceutical and biotechnology firms. In addition to testing services for the bio/pharmaceutical market, SGS also provides Phase I-IV clinical trial management, and services encompassing data management and statistics, PK/PD modeling and simulation, pharmacovigilance and regulatory consultancy.

For further information, please contact:

Jessica Martin
Global Head of Marketing, Life Sciences
SGS
t: +1 847 821 8900
www.sgs.com/lifescience

Richard Kerns
President
NEPR
t: +44 (0)161 728 5880

About SGS

SGS is the world's leading inspection, verification, testing and certification company. SGS is recognized as the global benchmark for quality and integrity. With more than 90,000 employees, SGS operates a network of over 2,000 offices and laboratories around the world.

SGS SA published this content on 08 August 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 08 August 2017 13:44:09 UTC.

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on SGS
10/16 SGS : EU Further Amends Proposal for BPA in Food Contact Materials and Articles
10/13 SGS CELEBRATES WORLD STANDARDS DAY 2 : Standards Make Cities Smarter
10/12 HOT SOURCE ISSUE 16 : Fipronil, Sustainability in Aquaculture, Monitoring Mycoto..
10/12 SGS : Increased Demand Raises the Risk of Seafood Production Shortfalls
10/12 SGS : Fipronil in Eggs – Another Food Issue in Europe
10/12 MONITORING MYCOTOXINS : Protecting the Food Industry
10/12 SGS : Practical FSMA Guidance for Foreign Suppliers
10/12 FIGHTING FRAUD : Detecting Intentional Adulteration in Milk
10/12 SGS : Agriculture & Food Testing in Morocco
10/12 SGS : Launches Chinese Visual Trust Initiative with Carrefour
More news
News from SeekingAlpha
2016 HEWL : A Legendary Investment
Financials ( CHF)
Sales 2017 6 270 M
EBIT 2017 955 M
Net income 2017 630 M
Debt 2017 765 M
Yield 2017 3,13%
P/E ratio 2017 27,45
P/E ratio 2018 25,19
EV / Sales 2017 2,94x
EV / Sales 2018 2,79x
Capitalization 17 642 M
Chart SGS
Duration : Period :
SGS Technical Analysis Chart | SGSN | CH0002497458 | 4-Traders
Technical analysis trends SGS
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 24
Average target price 2 232  CHF
Spread / Average Target -3,4%
EPS Revisions
Managers
NameTitle
Frankie Ng Chief Executive Officer
Sergio Marchionne Chairman
Carla D. F. de Geyseleer Chief Financial Officer & Senior Vice President
August François von Finck Independent Director
Shelby R. du Pasquier Independent Non-Executive Director
Sector and Competitors
1st jan.Capitalization (M$)
SGS12.26%18 017
FISERV19.57%26 651
CIELO SA-1.23%18 912
SECOM CO LTD0.88%17 912
FIRST DATA CORP24.17%16 688
CINTAS CORPORATION31.48%16 057